abstract |
The present invention relates to novel glycyrrhetinic acid derivatives of formula (I), compositions comprising the derivatives, and up-regulation of PPARĪ³ and / or one or more specificity (Sp) proteins, such as cancer, diabetes and Huntington's disease It relates to their use in the treatment of conditions or diseases that benefit from down-regulation of expression or activity. |